Paper Review Records
All Paper Review Records
14 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
4
days
ISoP MENA Chapter: Strategic Development and Future Directions Following a Decade of Strengthening Pharmacovigilance in the Middle East and North Africa
AuthorsHadir Rostom; Mohamed A. Elhawary; Mayada Alkhakany; Manal M. Younus; Thamir Alshammari; Felipe Villalobos; Omar Aimer
Affiliations1. ISoP MENA Chapter Founding Group, Cairo, Egypt; 2. Faculty of Pharmacy, MSA University, 6th of October City, Egypt; 3. International Society of Pharmacovigilance, ISoP Secretariat Ltd, London, UK; 4. Medical Affairs, SAJA Pharmaceuticals Co., Ltd, Jeddah, Saudi Arabia; 5. Seven D Consultancy, Dubai, UAE; 6. Iraqi Pharmacovigilance Centre, Ministry of Health, Baghdad, Iraq; 7. Department of Pharmacy Practice, College of Pharmacy, Jazan University, Jazan, Saudi Arabia; 8. Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan, Saudi Arabia; 9. Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain; 10. InnoVigilance, Laval, Canada
288
days
Safety and Management of Targeted Therapies for Relapsed/Refractory Chronic Lymphocytic Leukemia
AuthorsSikander Ailawadhi; Elcin Omercikoglu; Aneel Paulus; Ricardo D. Parrondo; Asher A. Chanan-Khan
Affiliations1. Division of Hematology-Oncology, Mayo Clinic, Jacksonville, USA; 2. Department of Cancer Biology, Mayo Clinic, Jacksonville, USA
176
days
Enhancing Disease Surveillance and Pharmacovigilance Practices for RTS,S/AS01 E Malaria Vaccine Rollout in Ghana, Kenya, and Malawi: Strategies, Impact, Challenges, and Lessons Learned
AuthorsValérie Haine; Tene-Alima Essoh; Caroline Perrin Franck; Miloje Savic
Affiliations1. GSK, Wavre, Belgium; 2. Agence de Médecine Préventive Afrique (AMP Afrique), Abidjan, Côte d’Ivoire; 3. Department of Radiology and Medical Informatics, Faculty of Medicine, University of Geneva, Geneva, Switzerland
75
days
Developing a Hierarchical Algorithm to Identify Pregnancies and Determine Gestational Age from Nationwide Linked Health Data in Taiwan
AuthorsMiyuki Hsing-Chun Hsieh; Zoe Chi-Jui Chang; Chih-Wan Lin; Brian Meng-Hsun Li; Edward Chia-Cheng Lai; Wan-Ting Huang
Affiliations1. School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan City, Taiwan; 2. Population Health Data Center, National Cheng Kung University, Tainan City, Taiwan; 3. Department of Pharmacy, Linkou Chang Gung Memorial Hospital, Taoyuan City, Taiwan; 4. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, USA; 5. Global Health Program, College of Public Health, National Taiwan University, Taipei City, Taiwan; 6. National Taiwan University Children’s Hospital, Taipei City, Taiwan
203
days
Safety and Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis: A Systematic Review and Meta-analysis
AuthorsWei Kang; Bowie P. Y. Lam; Rinko Tsz Lam Lau; Silvia T. H. Li; Kangrui Wu; Yue Wei; Yu Yang; Kyung Jin Lee; Caige Huang; Vincent K. C. Yan; Hei Hang Edmund Yiu; Shing Fung Lee; Aya El Helali; Victor H. F. Lee; Stephen L. Chan; Rina Y. M. Hui; Ka On Lam; Esther W. Chan
Affiliations1. School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China; 2. Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, China; 3. Institute of Health Economics and Policy, Tianjin University, Tianjin, China; 4. Schulich School of Medicine and Dentistry, Western University, London, Canada; 5. Institute of Clinical Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 6. Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore; 7. Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; 8. Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; 9. Clinical Oncology Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China; 10. State Key Laboratory of Translational Oncology, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR, China; 11. Centre of Cancer Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; 12. Accident and Emergency Department, Queen Mary Hospital, Pok Fu Lam, China; 13. Shenzhen Institute of Research and Innovation, The University of Hong Kong, Shenzhen, China
60
days
Analytic Misjudgment of Drug Safety Evidence and Causality: From the Prosecutor’s Fallacy and Simpson’s Paradox to Artificial Intelligence
AuthorsTarek A. Hammad; Justine Rochon
Affiliations1. Medical Safety of Marketed Products Development, Plasma-Derived Therapies, Devices, and Vaccines, Patient Safety and Pharmacovigilance, Takeda Development Center Americas, Inc., Cambridge, USA; 2. R&D Data and Quantitative Sciences, Takeda Development Center Americas, Inc., Cambridge, USA
158
days
A Large Language Model for Extracting Post-marketing Adverse Drug Events from Clinical Notes in the Electronic Health Record
AuthorsDana Ludwig; Michelle Wang; James Buchanan; Trang Trinh
Affiliations1. Bakar Computational Health Sciences Institute, University of California at San Francisco, San Francisco, USA; 2. Covilance, LLC, Belmont, USA; 3. Clinical Pharmacy, University of California at San Francisco, San Francisco, USA; 4. Pharmacotherapeutics & Clinical Research, University of South Florida Taneja College of Pharmacy, Tampa, USA
157
days
Assessing the Risk of Adverse Maternal and Infant Outcomes Following Prenatal Modafinil Exposure: A French Nationwide Cohort Study
AuthorsSigal Kaplan; Julie de Nascimento; Andrea Contini
Affiliations1. Epidemiology, Teva Pharmaceutical Industries Ltd., Netanya, Israel; 2. IQVIA, Real World Data, Paris, France
8
days
Global Perspective on the Evolution and Future of Pharmacovigilance: Deliverables from the 24th Annual Meeting of the International Society of Pharmacovigilance Celebrating 25 Years of Excellence
AuthorsMohamed A. Elhawary; Brian Edwards; Hadir Rostom; Shanthi N. Pal; Viola Macolic Sarinic; Priya Bahri; Deirdre McCarthy; Victoria Prudence Nambasa; Linda Härmark; Andrew Bate; Rebecca Chandler; Marco Tuccori; Fawaz Alharbi; Mohammed Fouda; Comfort Ogar; Jürgen Beckmann; Jayesh Pandit; Mayada Alkhakany; Christina Saad; Manal M. Younus; Ivor Ralph Edwards; Omar Aimer
Affiliations1. Egyptian Ministry of Health and Population (General Secretary of ISoP Egypt Chapter), Cairo, Egypt; 2. Faculty of Pharmacy, Ain Shams University, Cairo, Egypt; 3. International Society of Pharmacovigilance, ISoP Secretariat Ltd, London, UK; 4. Husoteria Consultancy Ltd, London, UK; 5. International Society of Pharmacovigilance-Egypt Chapter, Cairo, Egypt; 6. Faculty of Pharmacy, MSA University, Giza, Egypt; 7. Regulation and Safety, World Health Organization, Geneva, Switzerland; 8. European Medicines Agency, Amsterdam, The Netherlands; 9. International Society of Pharmacovigilance, Special Interest Group on Medicinal Product Risk Communication, Geneva, Switzerland; 10. Gates Foundation, Seattle, USA; 11. African Union Development Agency-NEPAD, Johannesburg, South Africa; 12. Drug Safety Research Unit, Southampton, UK; 13. Global Safety, GSK, Middlesex, UK; 14. Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK; 15. Coalition for Epidemic Preparedness Innovations, Oslo, Norway; 16. Section of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy; 17. Regional Centre of Pharmacovigilance-Veneto Region, Verona, Italy; 18. Saudi Food and Drug Authority, Riyadh, Saudi Arabia; 19. United States Pharmacopeia, Rockville, USA; 20. Berlin, Germany; 21. International Society of Pharmacovigilance Africa Chapter, Nairobi, Kenya; 22. Bayer Healthcare, Nairobi, Kenya; 23. International Society of Pharmacovigilance Patient Engagement Special Interest Group, London, UK; 24. Seven D Consultancy, Dubai, UAE; 25. Bayer Pharmaceuticals Inc., Cairo, Egypt; 26. International Society of Pharmacovigilance Middle East Chapter, Baghdad, Iraq; 27. Iraqi Pharmacovigilance Centre, Ministry of Health, Baghdad, Iraq; 28. Gothenburg, Sweden; 29. InnoVigilance, Laval, Canada
70
days
Incidence of Naloxone-Use Before and After Implementing Opioid Safety Measures for Patients Hospitalised on General Wards in a Swiss University Hospital
AuthorsAnja Jungo; Kanchan Dongre; Delia Halbeisen; Tobias Schneider; Sibylle Chettata; Niklaus Gygli; Murat Bilici; Christoph R. Meier; Anne B. Leuppi-Taegtmeyer
Affiliations1. Department of Pharmaceutical Science, University of Basel, Basel, Switzerland; 2. Department of Patient Safety, Medical Directorate, University Hospital Basel, Basel, Switzerland; 3. Department of Clinical Research, University of Basel, Basel, Switzerland; 4. Hospital Pharmacy, University Hospital Basel, Basel, Switzerland; 5. Clinic for Anaesthesia, Intermediate Care, Prehospital Emergency Medicine and Pain Therapy, University Hospital Basel, Basel, Switzerland; 6. Department of Nursing, Medical Directorate, University Hospital Basel, Basel, Switzerland; 7. Department of Quality Management, Medical Directorate, University Hospital Basel, Basel, Switzerland
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days